Table 1 Demographics and clinical characteristics.
Control group (n = 88) | GS group (n = 50) | NTG group (n = 73) | POAG group (n = 62) | P-value | Post-hoc P-values | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Control vs. GS | Control vs. NTG | Control vs. POAG | GS vs. NTG | GS vs. POAG | NTG vs. POAG | ||||||
Age (years) | 62.7 ± 4.5 | 61.0 ± 12.7 | 59.6 ± 15.1 | 62.8 ± 13.0 | 0.080 | ||||||
Sex (male, %) | 38 (43.2) | 23 (46.0) | 33 (45.2) | 30 (48.3) | 0.870 | ||||||
Laterality (right, %) | 51 (57.9) | 20 (40.0) | 47 (64.3) | 38 (61.3) | 0.071 | ||||||
BCVA (logMAR) | − 0.02 ± 0.05 | 0.06 ± 0.09 | 0.06 ± 0.15 | 0.07 ± 0.13 | < 0.001 | 0.001 | < 0.001 | < 0.001 | 0.999 | 0.847 | 0.862 |
SE (diopter) | − 0.59 ± 1.2 | − 0.77 ± 2.00 | − 1.24 ± 2.61 | − 1.02 ± 3.08 | 0.102 | ||||||
IOP (mmHg) | 14.9 ± 2.6 | 15.0 ± 2.8 | 12.4 ± 3.0 | 14.6 ± 3.3 | < 0.001 | 0.998 | < 0.001 | 0.870 | < 0.001 | 0.841 | < 0.001 |
AXL (mm) | 23.7 ± 0.8 | 23.8 ± 0.6 | 24.0 ± 0.5 | 24.2 ± 0.9 | 0.560 | ||||||
VF parameters | |||||||||||
MD (dB) | n/a | − 1.74 ± 2.49 | − 6.75 ± 7.80 | − 7.70 ± 7.93 | 0.005 | 0.016 | 0.004 | 0.737 | |||
PSD (dB) | n/a | 2.54 ± 1.12 | 4.52 ± 4.05 | 7.25 ± 4.33 | < 0.001 | < 0.001 | < 0.001 | 0.527 | |||
VFI (%) | n/a | 97.4 ± 3.8 | 80.1 ± 24.7 | 78.9 ± 23.7 | 0.003 | 0.006 | 0.003 | 0.946 | |||